Inborn errors of metabolism are genetic disorders in which a mutation disrupts a specific enzyme or protein involved in metabolic pathways, leading to the accumulation of toxic substances or deficiency of essential products. Research published in Glycomics And Metabolism addresses several distinct metabolic disorder…
Inborn errors of metabolism are genetic disorders in which a mutation disrupts a specific enzyme or protein involved in metabolic pathways, leading to the accumulation of toxic substances or deficiency of essential products. Research published in Glycomics And Metabolism addresses several distinct metabolic disorders and their potential treatments. One investigation examines Canavan disease, a fatal neurodegenerative condition caused by deficiency of the enzyme aspartoacylase, proposing a therapeutic approach that redirects metabolic processing to support the hypothesis that astrocyte dysfunction drives disease pathology. The journal has also explored hyperoxaluria, a metabolic disorder characterized by excessive urinary oxalate excretion that can lead to kidney damage, specifically in the context of refractory anemia. Additionally, published work has discussed fetal surgery as an intervention strategy for congenital metabolic conditions. These disorders collectively represent significant clinical challenges because they often manifest early in life and can cause progressive organ damage or neurological impairment if untreated. Understanding the underlying biochemical mechanisms and developing targeted interventions remains essential for improving outcomes in affected individuals.
3 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 3 articles above have been cited 6 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Inborn Errors of Metabolism, linking to each citing work.